Anaheim Clinical Trials, LLC
Anaheim, California CA 92801
3 studies enrolling now · 124 studies all time
What they study most
Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects, Acute Kidney Injury (Nontraumatic), Acute Post-surgical Pain, Acute-on-Chronic Liver Failure, Alzheimer's Disease, Analgesia, Asthma, Atopic Dermatitis, Bowel Preparation Before Colonoscopy, COVID-19, COVID-19 (Coronavirus Disease 2019), COVID-19 Prevention
Studies at this site
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients — Recruiting now
- A Study of LY3867070 in Healthy Participants — Recruiting now
- A Study to Learn About a Vaccine Against E Coli in Healthy Adults — Recruiting now
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight — Completed
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before — Completed
- A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3) — Completed
- Study of Post-Herniorrhaphy Non-opioid MMA Regimens — Completed
- A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954 — Completed
- A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight — Completed
- A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension — Running, not enrolling
- A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
- To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults — Running, not enrolling
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
- Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
- A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) — Stopped early
- Phase 2 Herniorrhaphy Study for Opioid Elimination — Completed
- Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2) — Completed
- Bunionectomy Study for Postoperative Analgesia (EPOCH 1) — Completed
- A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity — Completed
- A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity — Completed
- A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People — Completed
- Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers — Completed
- A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity — Completed
- Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty — Stopped early
- Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis — Completed
- To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
- A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals — Completed
- Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity — Stopped early
- A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese — Completed
- A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus — Completed
- A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older — Stopped early
- A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants — Completed
- A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 — Completed
- A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range — Stopped early
- A Study of LY3493269 in Participants With Type 2 Diabetes — Completed
- A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants — Stopped early
- A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity — Completed
- Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults — Completed
- A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883. — Completed
- STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS — Completed
- Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe — Completed
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity — Stopped early
- Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. — Completed
- A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults — Completed
- Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis — Completed
- Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia — Completed
- A Study of LY3848575 in Healthy Participants — Completed